Ahead of the Spending Review, an open letter to government from leaders across Cambridge, including the University’s Vice-Chancellor, sets out the clear case for renewed support for a region with a proven track record and which stands ready to deliver economic growth.
10 companies taking Cambridge ideas out of the lab and into the real world to address the climate emergency.
10 Cambridge spinouts on putting their research into practice to improve outcomes for cancer patients - and why Cambridge is a great place to do this.
This longstanding partnership between Cambridge, Arup and the Ove Arup Foundation has made our world safer and more sustainable and changed the way professionals are taught.
Meet the brilliant founder and CEO of Nu Quantum, a Cambridge spinout paving the way for a new era of quantum computing.
Cambridge Enterprise, the research commercialisation arm of the University of Cambridge, marked its 15th anniversary with a remarkable series of achievements.
Recruitment is underway in Cambridge for volunteers to take part in clinical trials of a revolutionary new needle-free vaccine to protect against SARS-CoV-2 – the virus that causes COVID-19 – and related coronaviruses.
Cambridge and BT have been working together for more than 25 years developing new technologies, exploring human behaviour and considering how those two things come together to shape our world.
Dr Giorgia Longobardi, founder and CEO of University spinout Cambridge GaN Devices, is harnessing the extraordinary properties of superconductor gallium nitride to halve the amount of energy we use to power our increasingly digital lives.
RegGenome, a commercial spin-out from the University of Cambridge, has announced the completion of a $6 million seed funding round.
© 2025 University of Cambridge
